Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMKK1 | Q8N5S9 | 2/20 | 0.33 |
| ▸ | CAMKK2 | Q96RR4 | 2/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | CPS1 | P31327 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10301834 | 0.92 | CAMKK1 (0.33) | CAMKK1CAMKK2FFAR1POLBMAOA | |
| SCHEMBL10301835 | 0.90 | CAMKK1 (0.30) | CAMKK1CAMKK2 | |
| SCHEMBL10301839 | 0.90 | CYP1A1 (0.35) | FFAR1MAOAMAOBCPS1 | |
| SCHEMBL10301838 | 0.88 | CHRNB2 (0.32) | CAMKK1CAMKK2POLBCPS1 | |
| SCHEMBL10301836 | 0.87 | CNR2 (0.33) | — | |
| SCHEMBL12734164 | 0.87 | FFAR1 (0.31) | CAMKK1CAMKK2FFAR4FFAR1POLB | |
| SCHEMBL10301837 | 0.87 | CHRNB2 (0.31) | CAMKK1CAMKK2POLB | |
| SCHEMBL10301841 | 0.87 | HPGD (0.32) | CAMKK1CAMKK2FFAR1POLB | |
| SCHEMBL14765855 | 0.86 | FFAR4 (0.37) | CAMKK1CAMKK2FFAR4FFAR1 | |
| SCHEMBL12734337 | 0.86 | FFAR4 (0.34) | CAMKK1CAMKK2FFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8216489-B2 | Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20110037024-A1 | THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110037024-A1 | THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | LEF1, LAS1L, L3MBTL3 | CAMKK1 2016/4885CAMKK2 2829/4885FFAR4 1669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.